Study Summary
This trial looks at how well people with anorexia nervosa process food compared to healthy controls, in order to develop more effective treatments.
Eligible Conditions
- Anorexia Nervosa
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 2 Secondary · Reporting Duration: 6 and 12 months
2 hours
Change of metabolism biomarker
Food aversion/anxiety
6 and 12 months
Psychopathology
Weight
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
300 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 and 12 months
Who is running the clinical trial?
University of California, DavisOTHER
843 Previous Clinical Trials
5,012,051 Total Patients Enrolled
University of TorontoOTHER
632 Previous Clinical Trials
721,488 Total Patients Enrolled
2 Trials studying Anorexia Nervosa
242 Patients Enrolled for Anorexia Nervosa
University of California, San DiegoLead Sponsor
1,028 Previous Clinical Trials
1,805,721 Total Patients Enrolled
13 Trials studying Anorexia Nervosa
1,007 Patients Enrolled for Anorexia Nervosa
Pei-an (Betty) Shih, MPM, PhDPrincipal Investigator - University of California, San Diego
University of California, San Diego
Eligibility Criteria
Age 18 - 55 · Female Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:References
- Nguyen, Nhien, Michelle Dow, Blake Woodside, J. Bruce German, Oswald Quehenberger, and Pei-an Betty Shih. 2019. “Food-intake Normalization of Dysregulated Fatty Acids in Women with Anorexia Nervosa”. Nutrients. MDPI AG. doi:10.3390/nu11092208.
- Shih, Pei-an Betty. 2017. “Integrating Multi-omics Biomarkers and Postprandial Metabolism to Develop Personalized Treatment for Anorexia Nervosa”. Prostaglandins & Other Lipid Mediators. Elsevier BV. doi:10.1016/j.prostaglandins.2017.02.002.
- Shih, Pei-an Betty, and D. Blake Woodside. 2016. “Contemporary Views on the Genetics of Anorexia Nervosa”. European Neuropsychopharmacology. Elsevier BV. doi:10.1016/j.euroneuro.2016.02.008.
- Shih, P B, J Yang, C Morisseau, J B German, A A Scott-Van Zeeland, A M Armando, O Quehenberger, et al.. 2015. “Dysregulation of Soluble Epoxide Hydrolase and Lipidomic Profiles in Anorexia Nervosa”. Molecular Psychiatry. Springer Science and Business Media LLC. doi:10.1038/mp.2015.26.
- Shih PA, Woodside DB. Contemporary views on the genetics of anorexia nervosa. Eur Neuropsychopharmacol. 2016 Apr;26(4):663-73. doi: 10.1016/j.euroneuro.2016.02.008. Epub 2016 Feb 20.
- Nguyen N, Dow M, Woodside B, German JB, Quehenberger O, Shih PB. Food-Intake Normalization of Dysregulated Fatty Acids in Women with Anorexia Nervosa. Nutrients. 2019 Sep 13;11(9):2208. doi: 10.3390/nu11092208.
- Pei-an (Betty) Shih 2016. "Study of Food Aversion in Patients With Anorexia Nervosa". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03100656.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments